Apr 14 |
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans
|
Apr 10 |
Terns Pharmaceuticals appoints Melita Sun Jung as chief business officer
|
Apr 10 |
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
|
Mar 14 |
Terns to report Phase 1 data on GLP-1 drug in 2H 2024
|
Mar 14 |
Terns Pharmaceuticals GAAP EPS of -$0.29
|
Mar 14 |
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
|
Mar 11 |
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
|
Feb 27 |
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
|
Feb 7 |
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
|
Feb 7 |
Terns Pharmaceuticals appoints Burroughs as CEO
|